ABBREVIATIONS
3-MC 3-methyl cholanthrene
5AC 5-azacytidine
5-mC 5-methylcytosine
5hmC 5-hydroxymethylcytosine
AhR Aryl hydrocarbon receptor
AhRKO Aryl hydrocarbon receptor knock-out
AOP Adverse outcome pathway
BPA Bisphenol A
bw Bodyweight
CoE CERAD Centre of Excellence for Environmental Radioactivity
CRO Contract research organisation
DBP Di-n-butyl phthalate (Dibutyl phthalate)
DEHP Diethylhexyl phthalate
DES Diethylstilbestrol
DNA Deoxyribonucleic acid
EDC Endocrine disrupting chemical
EGF Epidermal growth factor
EPA (US) Environmental Protection Agency
ER Oestrogen receptor
EU European Union
EWAS Epigenome-wide association studies
F1 First generation of offspring
F2 Second generation of offspring
F3 Third generation of offspring
F4 Fourth generation of offspring
FET Fish embryo toxicity
FGF Fibroblast growth factor
GD Gestation day
GLP Good Laboratory Practice
IGF-1 Insulin-like growth factor I
LC-MS Liquid chromatography - mass spectrometry
Lin Linuron
MEHP Mono(2 ethylhexyl)phthalate
miRNA MicroRNA
MoA Mode of action
MOE Margin of exposure
MRC Medical Research Council
ncRNA Non-coding ribonucleic acid
NGC Non-genotoxic carcinogen
NIHS National Institute of Health Sciences
NOAEL No observed adverse effect level
OECD Organisation for Economic Co-Operation and Development
P0 Parental generation
PBML Primary bone marrow lymphomas
nihsPPAR Peroxisome proliferator-activated receptor
PTMs Post-translational modifications
Q-PCR Quantitative polymerase chain reaction
QSAR Quantitative structure-activity relationship
RfP Request for proposal
RNA Ribonucleic acid
RRBS Reduced representation bisulphite sequencing
SD Sex determination
TCDD 2,3,7,8-tetrachlorinated dibenzo-p-dioxin / 2,3,7,8-tetrachlorodibenzo-p-dioxin
TDG Thymine-DNA glycosylase
TG Test Guideline
TGE Transgenerational effects
WD Wolffian duct